Matthew D. Vesely, M., Suguru Imaeda, M., & Brett A. King, M. (2017). Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis. Elsevier.
Chicago Style (17th ed.) CitationMatthew D. Vesely, MD, MD Suguru Imaeda, and MD Brett A. King. Tofacitinib Citrate for the Treatment of Refractory, Severe Chronic Actinic Dermatitis. Elsevier, 2017.
MLA (9th ed.) CitationMatthew D. Vesely, MD, et al. Tofacitinib Citrate for the Treatment of Refractory, Severe Chronic Actinic Dermatitis. Elsevier, 2017.
Warning: These citations may not always be 100% accurate.